A carregar...
Optimising plasma levels of clozapine during metabolic interactions: a review and case report with adjunct rifampicin treatment
BACKGROUND: Clozapine is the only licensed medication for treatment-resistant schizophrenia. The metabolism of clozapine is affected by multiple pharmacokinetic interactions, so the co-administration of adjunct medications can have a significant clinical effect. The anti- tuberculosis medication rif...
Na minha lista:
| Publicado no: | BMC Psychiatry |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4542109/ https://ncbi.nlm.nih.gov/pubmed/26265348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-015-0536-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|